Dublin, June 10, 2024 (GLOBE NEWSWIRE) -- The "Clinical Trial Supply and Logistics Market for Pharma 2024-2034" report has been added to ResearchAndMarkets.com's offering.
World revenue for the Clinical Trial Supply and Logistics for Pharma Market is set to surpass US$14.0 billion in 2024.
Improving diversity in clinical trials is essential to guaranteeing the safety and effectiveness of medical interventions for all populations. In order to address this imperative, sites and sponsors can play a crucial role by taking proactive steps to encourage diversity and inclusivity in clinical research.
In order to obtain deep insights into the priorities of patient communities, sites and sponsors must first give priority to community engagement. These insights can then be incorporated into study designs and logistical arrangements, such as offering remote and digitally enabled study participation.
Initiatives for community outreach should be long-term commitments that find and apply viable solutions, building confidence and reducing obstacles to participation for marginalised groups. By working together with community organisations, healthcare providers, and advocacy groups, researchers can better understand the social and political factors that influence health, cross linguistic and cultural barriers, spread the word about opportunities for clinical research, and allay fears and misconceptions.
It is recommended that clinical trials be designed with input from trial sites and patient communities in order to minimise barriers to participation and create inclusive eligibility criteria. Encouraging diverse participants by providing patient-centred, culturally competent care throughout the trial process creates a warm and encouraging atmosphere. Additionally, research staff should receive diversity training from sites and sponsors in order to address implicit biases, improve communication skills, and develop cultural sensitivity. Research teams can establish an equitable environment that promotes diverse participation in clinical trials by cultivating an inclusive and respectful culture.
Market Dynamics:
Key Market Driving Factors
- Move Towards Decentralized/Virtual Trials
- Increasing Possibilities for Conducting Clinical Trials in Asia Pacific Nations
- Growing Clinical Trials Volume
- Integrated Solution to Track Clinical Trials
Market Restraining Factors
- Clinical Trial and Medical Cold Chain Logistics
- Man-made or Natural Disruption in Transportation
- High Financial Cost
Market Opportunities
- AI and Machine Learning are Evolving with More Data
- Virtual Trials and Technology Are Gaining Acceptance among Patients and Sites
- Big Companies are driving the Market
Forecasts to 2034 and other analyses reveal commercial prospects
- In addition to revenue forecasting to 2034, the new study provides you with recent results, growth rates, and market shares.
- You will find original analyses, with business outlooks and developments.
- Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter's Five Forces Analysis, PEST Analysis and recent developments.
Segments Covered in the Report
Type
- CTS Manufacturing
- CTS Logistics & Distribution
- CT Supply Chain Management
- CTS Packaging & Storage
Phase
- Preclinical
- Phase I
- Phase II
- Phase III
- Phase IV
- Post Launch
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 26 leading national markets.
The report also includes profiles and for some of the leading companies in the Clinical Trial Supply and Logistics for Pharma Market, 2024 to 2034, with a focus on this segment of these companies' operations.
Leading companies profiled in the report
- Almac Group
- Bilcare Limited
- Biocair
- Catalent, Inc.
- COREX Logistics
- Eurofins Scientific
- FedEx
- ICON plc
- Intertek Group plc
- Kerry Logistics Network Limited
- Kuehne+Nagel
- Marken (A UPS Company)
- Mayne Pharma Group Limited
- Movianto
- NAF Pharma
- Oximio
- Parexel International Corporation
- PCI Pharma Services (PCI)
- Royal Cargo
- Thermo Fisher Scientific Inc.
- United Parcel Service, Inc.
- Yourway
In summary, the report provides you with the following knowledge:
- Revenue forecasts to 2034 for the Clinical Trial Supply and Logistics for Pharma Market, with forecasts for type and phase, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
- Revenue forecasts to 2034 for five regional and 26 key national markets
- Prospects for established firms and those seeking to enter the market - including company profiles for 22 of the major companies involved in the Clinical Trial Supply and Logistics for Pharma Market.
For more information about this report visit https://www.researchandmarkets.com/r/tl60zg
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
